These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18474223)

  • 1. Hepatitis C virus infection in mouse hepatoma cells co-expressing human CD81 and Sip-L.
    Yeh CT; Lai HY; Yeh YJ; Cheng JC
    Biochem Biophys Res Commun; 2008 Jul; 372(1):157-61. PubMed ID: 18474223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 293 cells over-expressing human ADI1 and CD81 are permissive for serum-derived hepatitis C virus infection.
    Cheng JC; Yeh YJ; Pai LM; Chang ML; Yeh CT
    J Med Virol; 2009 Sep; 81(9):1560-8. PubMed ID: 19626614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel HCV replication mouse model using human hepatocellular carcinoma xenografts.
    Guévin C; Lamarre A; Labonté P
    Antiviral Res; 2009 Oct; 84(1):14-22. PubMed ID: 19622372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse hepatic cells support assembly of infectious hepatitis C virus particles.
    Long G; Hiet MS; Windisch MP; Lee JY; Lohmann V; Bartenschlager R
    Gastroenterology; 2011 Sep; 141(3):1057-66. PubMed ID: 21699799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel robust hepatitis C virus mouse efficacy model.
    Zhu Q; Oei Y; Mendel DB; Garrett EN; Patawaran MB; Hollenbach PW; Aukerman SL; Weiner AJ
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3260-8. PubMed ID: 17005803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.
    Paeshuyse J; Kaul A; De Clercq E; Rosenwirth B; Dumont JM; Scalfaro P; Bartenschlager R; Neyts J
    Hepatology; 2006 Apr; 43(4):761-70. PubMed ID: 16557546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems.
    Cagnon L; Wagaman P; Bartenschlager R; Pietschmann T; Gao T; Kneteman NM; Tyrrell DL; Bahl C; Niven P; Lee S; Simmen KA
    J Virol Methods; 2004 Jun; 118(1):23-31. PubMed ID: 15158065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transmission in vitro of hepatitis C virus from persistently infected human B-cells to hepatoma cells by cell-to-cell contact.
    Valli MB; Serafino A; Crema A; Bertolini L; Manzin A; Lanzilli G; Bosman C; Iacovacci S; Giunta S; Ponzetto A; Clementi M; Carloni G
    J Med Virol; 2006 Feb; 78(2):192-201. PubMed ID: 16372297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cultures of human hepatocytes isolated from hepatitis C virus-infected cirrhotic livers as a model to study hepatitis C infection.
    Raymond VA; Selliah S; Ethier C; Houle R; Jouan L; Maniere T; Lamarre D; Willems B; Bilodeau M
    Liver Int; 2009 Jul; 29(6):942-9. PubMed ID: 19302183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferons alpha, beta, gamma each inhibit hepatitis C virus replication at the level of internal ribosome entry site-mediated translation.
    Dash S; Prabhu R; Hazari S; Bastian F; Garry R; Zou W; Haque S; Joshi V; Regenstein FG; Thung SN
    Liver Int; 2005 Jun; 25(3):580-94. PubMed ID: 15910496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell entry, efficient RNA replication, and production of infectious hepatitis C virus progeny in mouse liver-derived cells.
    Frentzen A; Anggakusuma ; Gürlevik E; Hueging K; Knocke S; Ginkel C; Brown RJ; Heim M; Dill MT; Kröger A; Kalinke U; Kaderali L; Kuehnel F; Pietschmann T
    Hepatology; 2014 Jan; 59(1):78-88. PubMed ID: 23873628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes.
    Watashi K; Hijikata M; Hosaka M; Yamaji M; Shimotohno K
    Hepatology; 2003 Nov; 38(5):1282-8. PubMed ID: 14578868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.
    Toma S; Yamashiro T; Arakaki S; Shiroma J; Maeshiro T; Hibiya K; Sakamoto N; Kinjo F; Tateyama M; Fujita J
    J Viral Hepat; 2009 Jul; 16(7):506-12. PubMed ID: 19302339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural killer cells inhibit hepatitis C virus expression.
    Li Y; Zhang T; Ho C; Orange JS; Douglas SD; Ho WZ
    J Leukoc Biol; 2004 Dec; 76(6):1171-9. PubMed ID: 15339939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD81 down-regulation on B cells is associated with the response to interferon-alpha-based treatment for chronic hepatitis C virus infection.
    Chang LL; Cheng PN; Chen JS; Young KC
    Antiviral Res; 2007 Jul; 75(1):43-51. PubMed ID: 17194487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactive oxygen species suppress hepatitis C virus RNA replication in human hepatoma cells.
    Choi J; Lee KJ; Zheng Y; Yamaga AK; Lai MM; Ou JH
    Hepatology; 2004 Jan; 39(1):81-9. PubMed ID: 14752826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.
    Murao K; Imachi H; Yu X; Cao WM; Nishiuchi T; Chen K; Li J; Ahmed RA; Wong NC; Ishida T
    Gut; 2008 May; 57(5):664-71. PubMed ID: 17998316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea as an inhibitor of hepatitis C virus RNA replication.
    Nozaki A; Morimoto M; Kondo M; Oshima T; Numata K; Fujisawa S; Kaneko T; Miyajima E; Morita S; Mori K; Ikeda M; Kato N; Tanaka K
    Arch Virol; 2010 Apr; 155(4):601-5. PubMed ID: 20204428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.